We are live on
!
Find out more
CG
Carmignac Gestion Portfolio holdings
AUM
$7.71B
1-Year Est. Return
4.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.91%
1 Year Est. Return
+4.02%
3 Year Est. Return
+85.13%
5 Year Est. Return
+112.24%
10 Year Est. Return
+570.29%
AUM
$13B
AUM Growth
+$677M
(+5.5%)
Cap. Flow
-$333M
Cap. Flow
% of AUM
-2.56%
Top 10 Holdings %
Top 10 Hldgs %
48.66%
Holding
87
New
6
Increased
29
Reduced
17
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WUBA
58.com Inc
WUBA
|
+$270M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$187M |
| 3 |
Meta Platforms (Facebook)
META
|
+$124M |
| 4 |
Banco Macro
BMA
|
+$109M |
| 5 |
T-Mobile US
TMUS
|
+$89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$246M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$215M |
| 3 |
American Airlines Group
AAL
|
+$213M |
| 4 |
Delta Air Lines
DAL
|
+$212M |
| 5 |
Southwest Airlines
LUV
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.05% |
| 2 | Energy | 16.79% |
| 3 | Materials | 16.06% |
| 4 | Communication Services | 15.87% |
| 5 | Technology | 10.36% |
Similar funds
CGH
EGM
AC
XT
AL
NAMA
AAB
SIAU
Carmignac Gestion's Q3 2017 Portfolio in Review
As of Q3 2017, Carmignac Gestion held 87 positions worth $13B, up 5.5% from $12.3B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Carmignac Gestion's Q3 2017 filing shows 6 new, 29 increased, 17 reduced and 14 closed positions. Its largest new stake was Splunk Inc: 2,983,480 shares worth $198M. The largest sale was Intercept Pharmaceuticals, Inc., an estimated $246M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Energy and Materials.
- Carmignac Gestion's largest Q3 2017 buy was Splunk Inc: 2,983,480 shares worth $198M.
- Carmignac Gestion added most to 58.com Inc in Q3 2017, an estimated $270M increase.
- Carmignac Gestion's biggest Q3 2017 reduction was Amazon, cutting an estimated $112M.
- Carmignac Gestion fully exited Intercept Pharmaceuticals, Inc. in Q3 2017, selling an estimated $246M.
- Carmignac Gestion's ten largest holdings make up 49% of its $13B portfolio in Q3 2017.
- Carmignac Gestion opened 6 new positions and closed 14 in Q3 2017.
- Carmignac Gestion's portfolio value rose 5.5% quarter-over-quarter to $13B.
Based on Carmignac Gestion's 13F filing for Q3 2017, filed 13 Nov 2017.